Corbus Pharmaceuticals Holdings (CRBP) Short-term Investments (2020 - 2025)

Corbus Pharmaceuticals Holdings' Short-term Investments history runs 6 years deep, the most recent figure standing at $134.8 million for Q4 2025.

• In Q4 2025, Short-term Investments rose 2.21% year-over-year to $134.8 million; the TTM figure through Dec 2025 stood at $134.8 million (up 2.21% YoY), while the FY2025 annual figure was $134.8 million, up 2.21% from the prior year.
• Short-term Investments for Q4 2025 stood at $134.8 million, up from $77.0 million in the prior quarter.
• The five-year high for Short-term Investments was $139.9 million in Q3 2024, with the low at $7.2 million in Q4 2023.
• The 5-year median for Short-term Investments is $70.1 million (2021), against an average of $72.8 million.
• The sharpest annual moves came in 2021 and 2023: Short-term Investments soared 20654.43% in 2021, then slumped 82.98% in 2023.
• Corbus Pharmaceuticals Holdings' Short-term Investments stood at $72.6 million in 2021, then tumbled by 41.91% to $42.2 million in 2022, then plunged by 82.98% to $7.2 million in 2023, then jumped by 1736.03% to $131.9 million in 2024, then increased by 2.21% to $134.8 million in 2025.
• Business Quant data shows CRBP's Short-term Investments at $134.8 million in Q4 2025, $77.0 million in Q3 2025, and $96.5 million in Q2 2025.